Oracle Investment Management as of June 30, 2021
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 25 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 26.1 | $226M | 2.3M | 97.08 | |
| Spdr Ser Tr S&p Biotech (XBI) | 14.1 | $122M | 901k | 135.39 | |
| Quidel Corporation | 12.4 | $107M | 837k | 128.12 | |
| Opko Health (OPK) | 6.3 | $55M | 14M | 4.05 | |
| Agenus Com New | 5.8 | $50M | 9.2M | 5.49 | |
| Aspira Womens Health | 5.6 | $49M | 8.6M | 5.62 | |
| Pacific Biosciences of California (PACB) | 5.5 | $48M | 1.4M | 34.97 | |
| Vir Biotechnology (VIR) | 4.9 | $43M | 902k | 47.28 | |
| Accelr8 Technology | 3.5 | $30M | 3.8M | 8.06 | |
| BioCryst Pharmaceuticals (BCRX) | 3.5 | $30M | 1.9M | 15.81 | |
| Dermtech Ord ord (DMTKQ) | 3.1 | $27M | 656k | 41.57 | |
| Codiak Biosciences | 1.5 | $13M | 679k | 18.53 | |
| Forian Ord (FORA) | 1.3 | $11M | 868k | 12.57 | |
| Y Mabs Therapeutics (YMAB) | 1.2 | $10M | 301k | 33.80 | |
| Antares Pharma | 1.0 | $8.3M | 1.9M | 4.36 | |
| Contrafect Corp Com New | 0.9 | $7.4M | 1.7M | 4.40 | |
| Capricor Therapeutics Com New (CAPR) | 0.7 | $6.0M | 1.2M | 5.13 | |
| Immutep Sponsored Ads (IMMP) | 0.4 | $3.9M | 1.0M | 3.87 | |
| Motus Gi Hldgs Incorporated | 0.4 | $3.8M | 3.7M | 1.04 | |
| Select Medical Holdings Corporation (SEM) | 0.4 | $3.7M | 89k | 42.26 | |
| Amarin Corp Spons Adr New (AMRN) | 0.4 | $3.7M | 851k | 4.38 | |
| Biodesix (BDSX) | 0.4 | $3.1M | 236k | 13.21 | |
| Soleno Therapeutics Com New | 0.3 | $2.4M | 2.1M | 1.14 | |
| Vertex Energy (VTNRQ) | 0.1 | $1.2M | 90k | 13.23 | |
| Biogen Idec (BIIB) | 0.1 | $835k | 2.4k | 346.19 |
